| |
 |
Marine Macrolides, a Promising Source of Antitumor Compounds
|
| |
|
pp.122-137 (16) Authors: Jose G. Napolitano, Antonio H. Daranas, Manuel Norte, Jose J. Fernandez |
| |
|
|
| |
|
Quercetin and Its Derivatives: Synthesis, Pharmacological Uses with Special Emphasis on Anti-Tumor Properties and Prodrug with Enhanced Bio-Availability
|
| |
|
pp.138-161 (24) Authors: Ketan V. Hirpara, Pawan Aggarwal, Amrita J. Mukherjee, Narendra Joshi, Anand C. Burman |
| |
|
|
| |
|
Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours
|
| |
|
pp.162-184 (23) Authors: Jose J.G. Marin, Marta R. Romero, Alba G. Blazquez, Elisa Herraez, Emma Keck, Oscar Briz |
| |
|
|
| |
|
Copper Complexes as Anticancer Agents
|
| |
|
pp.185-211 (27) Authors: Cristina Marzano, Maura Pellei, Francesco Tisato, Carlo Santini |
| |
|
|
| |
|
Role of Tyrosine Phosphatase Inhibitors in Cancer Treatment with Emphasis on SH2 Domain-Containing Tyrosine Phosphatases (SHPs)
|
| |
|
pp.212-220 (9) Authors: Mahban Irandoust, Timo K. van den Berg, Gertjan J.L. Kaspers, Jacqueline Cloos |
| |
|
|
| |
|
From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
|
| |
|
pp.221-229 (9) Authors: Isabelle Dussault, Steven F. Bellon |
| |
|
|
| |
|
Molecular Modeling Applied to Anti-Cancer Drug Development
|
| |
|
pp.230-238 (9) Authors: M. C. Rosales-Hernandez, J. Bermudez-Lugo, Jazmin Garcia, J. Trujillo-Ferrara, J. Correa-Basurto |
| |
|
|
| |
|
2-Deoxy-D-Ribose, a Downstream Mediator of Thymidine Phosphorylase, Regulates Tumor Angiogenesis and Progression
|
| |
|
pp.239-245 (7) Authors: Yuichi Nakajima, Radha Madhyastha, Masugi Maruyama |
| |
|
|
